References
- Anonymous (2002). Revision I. Version 4 x Y, Diagnostic Products Corporation, USA.
- Brooks, M. (2009). Breast cancer screening and biomarkers. Surg. Oncol., 18(1), 15-24.
- Carpelan-Holmström, M., Louhimo, J., Stenman, U.H., Alfthan, H., Haglund, C. (2002). CEA, CA 19-9 and CA 72-4 improve the diagnostic accuracy in gastrointestinal cancers. Anticancer Res. 22(4), 2311-2316.
- Chen, C.C., Yang, S.H., Lin, J.K., Lin, T.C., Chen, W.S., Jiang, J.K., Wang, H.S., Chang, S.C. (2005). Is it reasonable to add preoperative serum level of CEA and CA19-9 to staging for colorectal cancer? J. Surg. Res., 124(2), 169-74.
- Dbouk, H.A., Tawil, A., Nasr, F., Kandakarjian, L., Abou-Merhi, R. (2007). Significance of CEA and VEGF as Diagnostic Markers of Colorectal Cancer in Lebanese Patients. Open Clin. Cancer J., 1, 1-5.
- Delarue, J.C., Mouriesse, H., Dubois, F., Friedman, S., May-Levin, F. (1988). Markers in breast cancer: Does CEA add to the detection by CA 15.3? Breast Cancer Res. Treat., 11(3), 273-276.
- DeLellis, K., Ingles, S., Kolonel, L., McKean-Cowdin, R., Henderson, B., Stanczyk, F., Probst-Hensch, N.M. (2003). IGF1 genotype, mean plasma level and breast cancer risk in the Hawaii/Los Angeles multiethnic cohort. Brit. J. Cancer, 88(2), 277-282.
- Durai, R., Yang, W., Gupta, S., Seifalian, A.M., Winslet, M.C. (2005). The role of the insulin-like growth factor system in colorectal cancer: Review of current knowledge. Int. J. Colorectal Dis., 20(3), 203-220.
- Fernandes, L.C., Kim, S.B., Matos, D. (2005). Cytokeratins and carcino-embryonic antigen in diagnosis, staging and prognosis of colorectal adenocarcinoma. World J. Gastroenterol., 11(5), 645-648.
- Fürstenberger, G., Morant, R., Senn, H.J. (2003). Insulin-like growth factors and breast cancer. Onkologie, 26(3), 290-294.
- Hankinson, S.E., Willett, W.C., Colditz, G.A., Hunter, D.J., Michaud, D.S., Deroo, B., Rosner, B., Speizer, F.E., Pollak, M. (1998). Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet, 351(9113), 1393-1396.
- Holly, J.M., Gunnell, D.J., Davey Smith, G. (1999). Growth hormone, IGF-I and cancer. Less intervention to avoid cancer? More intervention to prevent cancer? J. Endocrinol., 162(3), 321-330.
- Jenkins, P.J., Bustin, S.A. (2004). Evidence for a link between IGF-I and cancer. Eur. J. Endocrinol., 151 (Suppl 1), S17-22.
- Johansson, H., Baglietto, L., Guerrieri-Gonzaga, A., Bonanni, B., Mariette, F., Macis, D., Serrano, D., Sandri, M.T., Decensi, A. (2004). Factors associated with circulating levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in 740 women at risk for breast cancer. Breast Cancer Res. Treat., 88(1), 63-73.
- Kaczka, A., Kumor, A., Pietruczuk, M., Malecka-Panas, E. (2007). Serum concentration of insulin, C-peptide and insulin-like growth factor I in patients with colon adenomas and colorectal cancer. Pol. Merkur Lekarski, 22(131), 373-375 (in Polish)
- Morimoto, L.M., Newcomb1, P.A., White, E., Bigler, J., Potter, J.D. (2005). Insulin-like growth factor polymorphisms and colorectal cancer risk. Cancer Epidemiol. Biomarkers Prevent., 14, 1204-1211.
- Duffy, M.J. (2001). Carcinoembryonic Antigen as a Marker for Colorectal Cancer: Is it clinically useful? Clinical Chemistry, 47, 624-630.
- Renehan, A.G., Zwahlen, M., Minder, C., O'Dwyer, S.T., Shalet, S.M., Egger, M. (2004). Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: Systematic review and meta-regression analysis. Lancet, 363(9418), 1346-1353.
- Schiemann, U., Günther, S., Gross, M., Henke, G., Müller-Koch, Y., König, A., Muders, M., Folwaczny, C., Mussack, T., Holinski-Feder, E. (2005). Preoperative serum levels of the carcinoembryonic antigen in hereditary non-polyposis colorectal cancer compared to levels in sporadic colorectal cancer. Cancer Detect. Prev., 29(4), 356-360.
- Tan, E., Gouvas, N., Nicholls, R.J., Ziprin, P., Xynos, E., Tekkis, P.P. (2009). Diagnostic precision of carcinoembryonic antigen in the detection of recurrence of colorectal cancer. Methods Mol. Biol., 472, 307-321.
- Tripkovic, I., Tripkovic, A., Strnad, M., Capkun, V., Zekan, L. (2007). Role of insulin-like growth factor-1 in colon cancerogenesis: A case-control study. Arch. Med. Res., 38(5), 519-525.